Subcutaneous erythropoietin therapy: efficacy and economic implications.

American journal of kidney diseases : the official journal of the National Kidney Foundation

Volumn 32, Issue 6 Suppl 4, 1998, Pages

  Kaufman, J S ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD; COST CONTROL; DOSE RESPONSE; ECONOMICS; HEMATOCRIT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; RENAL REPLACEMENT THERAPY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANEMIA; COST SAVINGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN, RECOMBINANT; HEMATOCRIT; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; RENAL DIALYSIS;

MLCS; MLOWN;

EID: 0032253569     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0272-6386(98)70178-7     Document Type: Article

References (0)